Literature DB >> 1270437

A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase.

C T Esmon, J Stenflo, J W Suttie.   

Abstract

Conclusive evidence is presented that a recently purified (Stenflo, J. (1976) J. Biol. Chem. 251, 355-363) vitamin K-dependent protein (arbitrarily referred to as Protein C) which is not related to prothrombin, Factors IX or X is also unrelated to Factor VII. It therefore appears to be a new, previously unrecognized vitamin K-dependent protein. In contrast to prothrombin, which binds to negatively charged phospholipid only in the presence of Ca2+ ions, Protein C, like the other vitamin K-dependent proteins, is a precursor of a serine esterase, presumably a protease, but it does not seem to be necessary for blood coagulation. Although the lipid-binding properties of Protein C may suggest that it is associated with membrane structures, its biological function remains unknown.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270437

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Mini-series: basic research-related reviews in intensive care medicine.

Authors:  Herwig Gerlach
Journal:  Intensive Care Med       Date:  2006-11-09       Impact factor: 17.440

2.  Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo.

Authors:  Laura D Healy; Cristina Puy; José A Fernández; Annachiara Mitrugno; Ravi S Keshari; Nyiawung A Taku; Tiffany T Chu; Xiao Xu; András Gruber; Florea Lupu; John H Griffin; Owen J T McCarty
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

3.  Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.

Authors:  Lea M Beaulieu; Frank C Church
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

4.  Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

Authors:  S Vigano D'Angelo; P C Comp; C T Esmon; A D'Angelo
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  Cloning and sequencing of liver cDNA coding for bovine protein C.

Authors:  G L Long; R M Belagaje; R T MacGillivray
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  Prevalence of resistence to activated protein C (APC-resistance) in blood donors in Kosovo.

Authors:  Ymer Mekaj; Bukurije Zhubi; Hakif Hoxha; Remzije Belegu; Agon Mekaj; Ermira Miftari; Mazllum Belegu
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

8.  beta-Hydroxyaspartic acid in vitamin K-dependent protein C.

Authors:  T Drakenberg; P Fernlund; P Roepstorff; J Stenflo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.

Authors:  R A Marlar; J H Griffin
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Characterization of a cDNA coding for human protein C.

Authors:  D Foster; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.